Higher red meat intake may increase risk for certain breast cancers

November 13, 2006

Eating more red meat may be associated with a higher risk for hormone receptor-positive breast cancers in premenopausal women, according to a report in the November 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

"Breast tumors are often characterized by hormone (estrogen and progesterone) receptor status," the authors write as background information in the article, meaning that the cancer is classified by whether these hormones can bind to proteins on the surface of the tumor. "Although the incidence rates of hormone receptor-negative tumors have remained relatively constant, the incidence of hormone receptor-positive tumors has been increasing in the United States, especially among middle-aged women." The diets of American women may be linked to this increase, since some foods--including certain components of red meat--can contain hormones or hormone-like compounds that influence tumors through their hormone receptors.

Eunyoung Cho, Sc.D., Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues studied the association between red meat consumption and breast cancer in 90,659 women who were part of the Nurses' Health Study II, a large ongoing study of nurses who responded to an initial questionnaire in 1989. Dr. Cho and colleagues followed the women from 1991 (when they had an average age of 36) through 2003. The participants filled out food questionnaires in 1991, 1995 and 1999, on which they recorded how often they regularly consumed more than 130 different foods and beverages. Every two years, they reported whether or not they had developed breast cancer; reported cases were confirmed through hospital records and pathology reports. Only women who were premenopausal and had not previously had cancer were included in this analysis, and those who went through natural menopause or had their ovaries removed during the 12 years of the study were excluded after that date.

By the end of the study, 1,021 women had developed breast cancer, including 512 cases that were estrogen and progesterone receptor positive, 167 that were estrogen and progesterone receptor negative, 110 with mixed status and 232 with unknown status. The highest intake of red meat was not significantly associated with the risk for breast cancer overall or for hormone receptor-negative cancers, but was associated with an increased risk for hormone receptor-positive cancer. Women who ate more than one and one-half servings of red meat per day had almost double the risk of hormone receptor-positive breast cancer compared with those who ate three or fewer servings per week. The associations remained similar when the researchers calculated red meat intake in grams instead of servings, and also when they split the women into five groups based on how much red meat they ate.

"Several biological mechanisms may explain the positive association between red meat intake and hormone receptor-positive breast cancer risk," the authors write. Known cancer-causing compounds in cooked or processed red meat increase mammary tumors in animals and have been suspected of causing breast cancer in humans. In addition, cattle in the United States are treated with hormones to promote growth, which could also influence breast cancer risk. The type of iron available in red meat also may enhance tumor formation.

"Given that most of the risk factors for breast cancer are not easily modifiable, these findings have potential public health implications in preventing breast cancer and should be evaluated further," the authors conclude.
-end-
(Arch Intern Med. 2006;166:2253-2259. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: This study was supported by a research grant from the National Institutes of Health. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.

The JAMA Network Journals

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.